Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0001493215-26-000026·Apellis Pharmaceuticals, Inc.
Schedule 13G ownership disclosure
Apellis Pharmaceuticals Inc
Common Stock, $0.0001 par value · CUSIP: 03753U106
Event date: 2025-12-31
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- RTW Investments, LP
Shares: 7,666,764.00 · Class: 6.1%
- Roderick Wong
Shares: 7,666,764.00 · Class: 6.1%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001493215-26-000026
- Form type
- SCHEDULE 13G
- Filer
- Apellis Pharmaceuticals, Inc.
- CIK
- CIK 1492422
- Filed
- Feb 17, 2026
- Reporting period
- Dec 31, 2025
- Description
- Schedule 13G beneficial ownership